We are live on ! Find out more
HCA

Harbor Capital Advisors Portfolio holdings

AUM $1.47B
1-Year Est. Return 42.58%
This Fund
S&P 500
This Quarter Est. Return
+10.26%
1 Year Est. Return
+42.58%
3 Year Est. Return
+118.91%
5 Year Est. Return
10 Year Est. Return
AUM
$500M
AUM Growth
+$153M
Cap. Flow
+$116M
Cap. Flow %
23.27%
Top 10 Hldgs %
22.86%
Holding
667
New
421
Increased
81
Reduced
65
Closed
6

Top Buys

Rank Stock Value
1
NSP icon
Insperity
NSP
+$2.52M
2
EVR icon
Evercore
EVR
+$2.38M
3
ABG icon
Asbury Automotive
ABG
+$2.29M
4
LIN icon
Linde
LIN
+$2.17M
5
FUL icon
H.B. Fuller
FUL
+$2.16M

Top Sells

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$3.44M
2
BALL icon
Ball Corp
BALL
+$2.53M
3
MCHP icon
Microchip Technology
MCHP
+$2.18M
4
NEE icon
NextEra Energy
NEE
+$1.92M
5
TEAM icon
Atlassian
TEAM
+$1.75M

Sector Composition

Rank Sector Weight
1 Technology 27.38%
2 Healthcare 16.78%
3 Financials 11.23%
4 Consumer Discretionary 8.28%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
201
Arrowhead Research
ARWR
$12.6B
$615K 0.12%
17,255
+1,593
+10% +$54.9K
SBAC icon
202
SBA Communications
SBAC
$19.3B
$606K 0.12%
2,614
+45
+2% +$10.8K
OBK icon
203
Origin Bancorp
OBK
$1.66B
$599K 0.12%
+20,442
New +$612K
REPL icon
204
Replimune Group
REPL
$1.15B
$598K 0.12%
25,768
+2,336
+10% +$45.6K
ARGO
205
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$591K 0.12%
+19,964
New +$587K
MRVL icon
206
Marvell Technology
MRVL
$191B
$583K 0.12%
9,759
AUTL
207
Autolus Therapeutics
AUTL
$620M
$582K 0.12%
244,541
+22,392
+10% +$53.1K
UNH icon
208
UnitedHealth
UNH
$365B
$580K 0.12%
1,207
+2
+0.2% +$978
BHVN icon
209
Biohaven
BHVN
$2.18B
$579K 0.12%
+24,189
New +$416K
RMD icon
210
ResMed
RMD
$32.6B
$578K 0.12%
2,644
STZ icon
211
Constellation Brands
STZ
$22.9B
$576K 0.12%
2,341
NTLA icon
212
Intellia Therapeutics
NTLA
$1.68B
$571K 0.11%
13,994
+390
+3% +$15.8K
MASI
213
DELISTED
Masimo
MASI
$570K 0.11%
+3,466
New +$603K
LGIH icon
214
LGI Homes
LGIH
$1.34B
$570K 0.11%
+4,222
New +$506K
LNTH icon
215
Lantheus
LNTH
$6.57B
$567K 0.11%
6,752
-1,272
-16% -$114K
PCG icon
216
PG&E
PCG
$38.1B
$565K 0.11%
32,721
NBR icon
217
Nabors Industries
NBR
$1.3B
$565K 0.11%
+6,076
New +$618K
VMW
218
DELISTED
VMware, Inc
VMW
$564K 0.11%
3,926
-190
-5% -$24.7K
SDGR icon
219
Schrodinger
SDGR
$1.4B
$560K 0.11%
+11,216
New +$379K
ALKS icon
220
Alkermes
ALKS
$8.26B
$558K 0.11%
17,839
-20,290
-53% -$614K
APPF icon
221
AppFolio
APPF
$7.19B
$558K 0.11%
+3,241
New +$472K
CALX icon
222
Calix
CALX
$2.49B
$556K 0.11%
+11,135
New +$537K
MSCI icon
223
MSCI
MSCI
$40.8B
$555K 0.11%
1,182
+22
+2% +$10.7K
TMO icon
224
Thermo Fisher Scientific
TMO
$224B
$550K 0.11%
1,054
+77
+8% +$41.6K
EXPE icon
225
Expedia Group
EXPE
$38.5B
$549K 0.11%
5,015

Similar funds

Harbor Capital Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Harbor Capital Advisors held 667 positions worth $500M, up 44% from $347M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Harbor Capital Advisors deployed $116M of net new capital in Q2 2023, opening 421 new positions and adding to 81 existing holdings. Its largest new stake was Insperity: 21,189 shares worth $2.52M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Workday, an estimated $3.44M trimmed.

  • Harbor Capital Advisors's largest Q2 2023 buy was Insperity: 21,189 shares worth $2.52M.
  • Harbor Capital Advisors added most to Advanced Micro Devices in Q2 2023, an estimated $1.52M increase.
  • Harbor Capital Advisors's biggest Q2 2023 reduction was Workday, cutting an estimated $3.44M.
  • Harbor Capital Advisors fully exited Ball Corp in Q2 2023, selling an estimated $2.53M.
  • Harbor Capital Advisors's ten largest holdings make up 23% of its $500M portfolio in Q2 2023.
  • Harbor Capital Advisors opened 421 new positions and closed 6 in Q2 2023.
  • Harbor Capital Advisors's portfolio value rose 44% quarter-over-quarter to $500M.

Based on Harbor Capital Advisors's 13F filing for Q2 2023, filed 11 Jul 2023.